Saturna Capital Corp Unity Biotechnology, Inc. Transaction History

Saturna Capital Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$0.72 - $1.86 $21,600 - $55,800	-30,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.51 - $9.42 $165,300 - $282,600	-30,000 Reduced 50.0%	30,000 $180,000
Q4 2020 Feb 12, 2021	BUY	$3.42 - $6.36 $102,600 - $190,800	30,000 Added 100.0%	60,000 $314,000
Q3 2020 Nov 10, 2020	BUY	$2.94 - $12.43 $20,580 - $87,010	7,000 Added 30.43%	30,000 $104,000
Q1 2020 May 14, 2020	BUY	$5.0 - $7.6 $10,000 - $15,200	2,000 Added 9.52%	23,000 $133,000
Q3 2019 Nov 14, 2019	BUY	$5.62 - $9.63 $118,020 - $202,230	21,000 New	21,000 $128,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Saturna Capital Corp with notifications on news.